Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Crinum moorei
Plante bulbuleuse sud-africaine utilisée en médecine zulou pour les troubles respiratoires, édimentations et eméticé.
Crinum moorei is a South African bulbous plant traditionally used in Zulu medicine for respiratory conditions, edema, and as an emetic. Its primary active compounds include the alkaloids lycorine and crinamine, which contribute to its expectorant, diuretic, and antimicrobial properties. Evidence for its efficacy is limited (Level C), with most data derived from traditional use and preliminary pharmacological studies.
The alkaloids in Crinum moorei, particularly lycorine and crinamine, exhibit cholinergic activity by inhibiting acetylcholinesterase, leading to increased bronchial secretions and expectorant effects. Lycorine also demonstrates antimicrobial activity against certain bacteria and fungi, possibly through disruption of microbial cell membranes. The emetic action is likely due to stimulation of the chemoreceptor trigger zone (CTZ) via dopaminergic and serotonergic pathways, while diuretic effects may involve modulation of renal ion channels. At high doses, cardiac toxicity can occur, possibly from alkaloid-induced sodium/potassium pump inhibition or direct myocardial depression.
Plante bulbuleuse sud-africaine utilisée en médecine zulou pour les troubles respiratoires, édimentations et eméticé.
Crinum moorei is a South African bulbous plant traditionally used in Zulu medicine for respiratory conditions, edema, and as an emetic. Its primary active compounds include the alkaloids lycorine and crinamine, which contribute to its expectorant, diuretic, and antimicrobial properties. Evidence for its efficacy is limited (Level C), with most data derived from traditional use and preliminary pharmacological studies.
The alkaloids in Crinum moorei, particularly lycorine and crinamine, exhibit cholinergic activity by inhibiting acetylcholinesterase, leading to increased bronchial secretions and expectorant effects. Lycorine also demonstrates antimicrobial activity against certain bacteria and fungi, possibly through disruption of microbial cell membranes. The emetic action is likely due to stimulation of the chemoreceptor trigger zone (CTZ) via dopaminergic and serotonergic pathways, while diuretic effects may involve modulation of renal ion channels. At high doses, cardiac toxicity can occur, possibly from alkaloid-induced sodium/potassium pump inhibition or direct myocardial depression.